-
公开(公告)号:US20130113632A1
公开(公告)日:2013-05-09
申请号:US13730696
申请日:2012-12-28
Applicant: Abbott Diabetes Care Inc.
Inventor: Daniel Bernstein , Jared Watkin , Martin J. Fennell , Mark K. Sloan , Michael Love , Namvar Kiaie , Jean-Pierre Cole , Steve Scott
IPC: G08C17/02
CPC classification number: A61B5/14542 , A61B5/0017 , A61B5/002 , A61B5/0031 , A61B5/14532 , A61B5/14546 , A61B5/14865 , A61B2560/0223 , A61B2560/0252 , A61B2560/0276 , A61B2560/045 , A61B2560/0456 , G06F19/00 , G06F19/3418 , G06Q50/22 , G06Q50/24 , G08C17/02 , G16H10/40 , G16H40/63 , G16H50/20
Abstract: Methods and devices and systems including a data collection module for receiving and storing analyte data over a predetermined time period from a subject, a user interface unit coupled to the data collection module for providing one or more indication related to the analyte data, a control unit coupled to the data collection module and the user interface unit to control, at least in part the operation of the data collection module and the user interface unit, a communication module coupled to the control unit for communicating one or more signals associated with the analyte data to a remote location, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of the analyte level received by the data collection module, and a retrospective analysis mode including limited output of information to the subject during the predetermined time period, and further where the communication module is configured to communicate with the remote location after the analyte data is received and stored in the data collection module over the predetermined time period, are provided.
Abstract translation: 包括用于在来自受试者的预定时间段内接收和存储分析物数据的数据收集模块的方法和装置和系统,耦合到数据收集模块的用户界面单元,用于提供与分析物数据相关的一个或多个指示;控制单元 耦合到所述数据收集模块和所述用户接口单元,以至少部分地控制所述数据收集模块和所述用户接口单元的操作;耦合到所述控制单元的通信模块,用于传送与所述分析物数据相关联的一个或多个信号 到远程位置,其中用户界面单元被配置为以包括基本上实时输出由数据收集模块接收的分析物水平的预期分析模式进行操作,以及回顾性分析模式,包括在所述受试者期间信息的有限输出 预定的时间段,并且进一步地,通信模块被配置为与之通信 提供了在预定时间段之后接收并存储在数据收集模块中的分析物数据之后的远程位置。
-
公开(公告)号:US20230268071A1
公开(公告)日:2023-08-24
申请号:US18176293
申请日:2023-02-28
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Daniel Milfred Bernstein , Martin J. Fennell , Mark Kent Sloan , Michael Love , Lei He , Christopher Allen Thomas , Udo Hoss , Benjamin Jay Feldman , Kenneth J. Doniger , Gary Ashley Stafford , Gary Alan Hayter , Phillip Yee , Namvar Kiaie , Jean-Pierre Cole , Marc Barry Taub , Louis George Pace , Jeffery Mario Sicurello
IPC: G16H40/67 , G01N33/487 , A61B5/00 , A61B5/145 , A61B5/1486 , A61B5/01 , G16H40/63
CPC classification number: G16H40/67 , G01N33/48792 , A61B5/0017 , A61B5/14532 , A61B5/1486 , A61B5/0022 , A61B5/01 , A61B5/72 , G16H40/63 , Y02A90/10 , A61B2560/0238
Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
-
公开(公告)号:US20230238131A1
公开(公告)日:2023-07-27
申请号:US18130381
申请日:2023-04-03
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Daniel Milfred Bernstein , Martin J. Fennell , Mark Kent Sloan , Michael Love , Lei He , Christopher Allen Thomas , Udo Hoss , Benjamin Jay Feldman , Kenneth J. Doniger , Gary Ashley Stafford , Gary Alan Hayter , Phillip Yee , Namvar Kiaie , Jean-Pierre Cole , Marc Barry Taub , Louis George Pace , Jeffery Mario Sicurello
IPC: G16H40/67 , G01N33/487 , A61B5/00 , A61B5/145 , A61B5/1486 , A61B5/01 , G16H40/63
CPC classification number: G16H40/67 , G01N33/48792 , A61B5/0017 , A61B5/14532 , A61B5/1486 , A61B5/0022 , A61B5/01 , A61B5/72 , G16H40/63 , Y02A90/10 , A61B2560/0238
Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.
-
14.
公开(公告)号:US11553883B2
公开(公告)日:2023-01-17
申请号:US15742502
申请日:2016-07-08
Applicant: Abbott Diabetes Care Inc.
Inventor: Gary Alan Hayter , Nathan Christopher Crouther , Michael Love , Erwin Satrya Budiman , Daniel Milfred Bernstein
Abstract: Method, device and system for providing consistent and reliable glucose response information to physiological changes and/or activities is provided to improve glycemic control and health management.
-
公开(公告)号:US20220240821A1
公开(公告)日:2022-08-04
申请号:US17720947
申请日:2022-04-14
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Wesley Scott Harper , Annie C. Tan , Timothy Christian Dunn , Mark Kent Sloan , Kenneth J. Doniger , Michael Love , Phillip Yee , Gary Alan Hayter , R. Curtis Jennewine , Glenn Howard Berman
IPC: A61B5/145
Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
-
公开(公告)号:USD957642S1
公开(公告)日:2022-07-12
申请号:US29776978
申请日:2021-04-01
Applicant: ABBOTT DIABETES CARE INC.
Designer: Christopher Allen Thomas , Udo Hoss , Martin J. Fennell , Lei He , Michael Love , Phillip Yee
-
公开(公告)号:USD955599S1
公开(公告)日:2022-06-21
申请号:US29776977
申请日:2021-04-01
Applicant: ABBOTT DIABETES CARE INC.
Designer: Christopher Allen Thomas , Udo Hoss , Martin J. Fennell , Lei He , Michael Love , Phillip Yee
-
公开(公告)号:US10918342B1
公开(公告)日:2021-02-16
申请号:US17067443
申请日:2020-10-09
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Wesley Scott Harper , Annie C. Tan , Timothy Christian Dunn , Mark Kent Sloan , Kenneth J. Doniger , Michael Love , Phillip Yee , Gary Alan Hayter , R. Curtis Jennewine , Glenn Howard Berman
Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
-
公开(公告)号:US10881355B2
公开(公告)日:2021-01-05
申请号:US16902111
申请日:2020-06-15
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Wesley Scott Harper , Annie C. Tan , Timothy Christian Dunn , Mark Kent Sloan , Kenneth J. Doniger , Michael Love , Phillip Yee , Gary Alan Hayter , R. Curtis Jennewine , Glenn Howard Berman
Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
-
公开(公告)号:US20200305803A1
公开(公告)日:2020-10-01
申请号:US16902111
申请日:2020-06-15
Applicant: ABBOTT DIABETES CARE INC.
Inventor: Wesley Scott Harper , Annie C. Tan , Timothy Christian Dunn , Mark Kent Sloan , Kenneth J. Doniger , Michael Love , Phillip Yee , Gary Alan Hayter , R. Curtis Jennewine , Glenn Howard Berman
Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
-
-
-
-
-
-
-
-
-